Christian B. Dinneen-Long

Consigliere Generale presso GLYCOMIMETICS, INC.

Health Technology

Consumer Services

Profilo

Christian B.
Dinneen-Long is currently serving as the Secretary, Vice President & Corporate Counsel at GlycoMimetics, Inc. Prior to this, he held positions as the Assistant General Counsel at Guilford Pharmaceuticals, Inc., the Associate General Counsel at Emergent BioSolutions, Inc., and the Senior Counsel at Medimmune, Inc. Mr. Dinneen-Long completed his undergraduate degree at the University of Wisconsin and his graduate degree at Chicago-Kent College of Law.

Posizioni attive di Christian B. Dinneen-Long

Società	Posizione	Inizio
GLYCOMIMETICS, INC.	Consigliere Generale	29/04/2019

Tutte le posizioni attive di Christian B. Dinneen-Long

Precedenti posizioni note di Christian B. Dinneen-Long

Società	Posizione	Fine
EMERGENT BIOSOLUTIONS INC.	Consigliere Generale	-
Guilford Pharmaceuticals, Inc. Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury	Consigliere Generale	-
Medimmune, Inc.	Consigliere Generale	-

Vedi nel dettaglio l'esperienza di Christian B. Dinneen-Long

Formazione di Christian B. Dinneen-Long

Chicago-Kent College of Law	Graduate Degree
University of Wisconsin	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Christian B. Dinneen-Long

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
GLYCOMIMETICS, INC.	Health Technology
EMERGENT BIOSOLUTIONS INC.	Health Technology

Aziende private	2
Medimmune, Inc.	Health Technology
Guilford Pharmaceuticals, Inc. Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury	Health Technology